Sepsis News and Research

Latest Sepsis News and Research

Pregnant women with H1N1 flu strain are at risk for obstetrical complications: Study

Pregnant women who contract the H1N1 flu strain are at risk for obstetrical complications including fetal distress, premature delivery, emergency cesarean delivery and fetal death, according to a report in the May 24 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

25 May 2010

British Columbia first in Canada to include Prevnar 13 in routine child immunization program

British Columbia is leading the way in vaccinations to protect children from serious disease. The province is the first in Canada to include Prevnar 13, the vaccine that provides the broadest coverage available against Streptococcus pneumoniae that may cause invasive pneumococcal disease, in the routine child immunization program.

21 May 2010

Tel Aviv University researcher develops tool to measure tissue damage in bed-ridden, paralyzed patients

There's currently no reliable tool to help prosthetic developers fit artificial limbs without ensuing discomfort or pain, or tell medical personnel when bed-ridden patients need to be moved to avoid bedsores and other problems.

19 May 2010

Human stem cells restore alveolar epithelial tissue after E. coli endotoxin-induced ALI: Researchers

Human stem cells administered intravenously can restore alveolar epithelial tissue to a normal function in a novel ex vivo perfused human lung after E. coli endotoxin-induced acute lung injury, according to research from the University of California San Francisco.

18 May 2010

BioMS reports consolidated net income of $6.5M for first-quarter 2010 compared to net loss of $3.8M in 2009

BioMS Medical Corp., today announced financial and operational results for the three months ended March 31, 2010.

15 May 2010

Experts address fundamental questions related to renal failure in ICU

Despite the fact that recent medical advances have allowed healthcare professionals to stabilize patients who would have otherwise died, many stabilized patients later develop organ system failure. In fact, acute renal failure is one of the biggest threats to critically ill patients: forty percent of patients with this condition die.

14 May 2010

MRSA Survivors Network to raise awareness on MRSA infections

More Americans die annually from invasive methicillin-resistant Staphylococcus aureus infections than from HIV/AIDS, H1N1 influenza and Parkinson's disease, yet the United States and many other countries' health officials continue to ignore the global crisis.

12 May 2010

Benefits outweigh risks in myeloablative therapy for children with high-risk neuroblastoma

Neuroblastoma is among the most common of childhood cancers and fortunately, some children will get better spontaneously. Yet for children with high-risk disease the outlook is poor: more than half will relapse despite chemotherapy.

12 May 2010

Opinions: Abortion in Canada's G8 initiative; Security of Afghan women; U.S. global development strategy; Mother's Day; U.S. food security initiative; Polio eradication

National Post columnist Jonathan Kay examines the ongoing debate over whether Canada's G8 child and maternal health initiative should include abortions, which according to a 2006 Oxford University Press-World Bank report, are "one small chunk of a bigger puzzle. A much larger problem, in terms of the number of female lives affected, is the decidedly less headline-grabbing subject of hemorrhages - which include antepartun hemorrhages … and primary postpartum hemorrhages.

12 May 2010

Astute Medical completes $26.5 million series B financing

Astute Medical, Inc., a developer of novel, biomarker-based medical diagnostics, today announced completion of a $26.5 million series B financing co-led by Domain Associates and Delphi Ventures. Astute will use the funding to advance research and development aimed at the identification and validation of protein biomarkers with the goal of commercializing high potential diagnostic products.

10 May 2010

Lancet examines Canada's G8 strategy for maternal, child health initiatives

A Lancet World Report examines the details of the Canadian government's strategy for the G8 maternal and child health initiative and reactions from global health leaders and politicians to the plan, including the announcement during a meeting of G8 leaders Halifax, Nova Scotia, that the initiative would not support abortion.

10 May 2010

Allos Therapeutics reports net loss of $20.5 million for first-quarter 2010

Allos Therapeutics, Inc. today reported financial results for the first quarter ended March 31, 2010.

6 May 2010

NIAID researchers initiate trial of DAS181 in patients with asthma, bronchiectasis

NexBio, Inc. announced today the initiation of a trial of DAS181 (Fludase®) in patients with the respiratory conditions asthma and bronchiectasis, being conducted by researchers with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). This trial will examine the effects of DAS181 in subjects with well-controlled or stable pulmonary disease.

3 May 2010

Implementation of quality improvement intervention reduces medication use in premature babies: Study

A new study by Pediatrix Medical Group researchers has found that the implementation of a quality improvement intervention significantly reduces the use of a large number of medications in premature babies across a broad neonatal intensive care network.

3 May 2010

Leptin hormone controls immune’s response to sepsis: Study

The hormone leptin, typically associated with body weight regulation, works within the central nervous system (CNS) to aid the immune system's defense against sepsis, researchers say.

3 May 2010

Probiotic supplementation helps ELBW infants gain weight: Study

Extremely low birthweight infants who received feedings supplemented with probiotics had better weight gain than infants who were not given the supplements, according to a randomized, controlled, double-blind study to be presented Saturday, May 1 at the Pediatric Academic Societies annual meeting in Vancouver, British Columbia, Canada.

3 May 2010

CBC, Scarab Genomics form agreement to increase manufacturing yield of Solinex rhu-pGSN

Critical Biologics Corporation (CBC) and Scarab Genomics announced today a strategic agreement to substantially increase the manufacturing yield of CBC's lead therapeutic protein candidate, Solinex™, an intravenous formulation of recombinant human plasma gelsolin (rhu-pGSN).

30 Apr 2010

New data on Cimzia for Crohn’s Disease treatment to be demonstrated at DDW 2010

Studies and analyses of the Crohn’s Disease (CD) treatment Cimzia® (certolizumab pegol) demonstrating new data will be exhibited at Digestive Disease Week (DDW) 2010, taking place in New Orleans from May 1-5, 2010.

30 Apr 2010

Artisan Pharma enrolls 750 patients in Phase 2b study of ART-123 in sepsis patients with DIC

Artisan Pharma, Inc., a private biopharmaceutical company dedicated to bringing best-in-class critical care therapeutics to patients, today announced the completion of patient enrollment in its Phase 2b study of ART-123 (Recomodulin® - recombinant human thrombomodulin) in sepsis patients with disseminated intravascular coagulation (DIC). The clinical trial was a randomized, double-blind, placebo-controlled Phase 2b study to assess the safety and efficacy of ART-123 in patients with sepsis and DIC.

30 Apr 2010

miacom diagnostics announces new tests for faster diagnosis of sepsis

"Conventional PCR tests (PCR is short for polymerase chain reaction, a highly sensitive method of detecting nucleic acids) require several hours to produce a result. lucesco Bacteremia IVD panels are not only much faster with a result after only 30 minutes, they are also much more cost-efficient.

29 Apr 2010

Sepsis News and Research

Latest Sepsis News and Research

Pregnant women with H1N1 flu strain are at risk for obstetrical complications: Study

British Columbia first in Canada to include Prevnar 13 in routine child immunization program

Tel Aviv University researcher develops tool to measure tissue damage in bed-ridden, paralyzed patients

Human stem cells restore alveolar epithelial tissue after E. coli endotoxin-induced ALI: Researchers

BioMS reports consolidated net income of $6.5M for first-quarter 2010 compared to net loss of $3.8M in 2009

Experts address fundamental questions related to renal failure in ICU

MRSA Survivors Network to raise awareness on MRSA infections

Benefits outweigh risks in myeloablative therapy for children with high-risk neuroblastoma

Opinions: Abortion in Canada's G8 initiative; Security of Afghan women; U.S. global development strategy; Mother's Day; U.S. food security initiative; Polio eradication

Astute Medical completes $26.5 million series B financing

Lancet examines Canada's G8 strategy for maternal, child health initiatives

Allos Therapeutics reports net loss of $20.5 million for first-quarter 2010

NIAID researchers initiate trial of DAS181 in patients with asthma, bronchiectasis

Implementation of quality improvement intervention reduces medication use in premature babies: Study

Leptin hormone controls immune’s response to sepsis: Study

Probiotic supplementation helps ELBW infants gain weight: Study

CBC, Scarab Genomics form agreement to increase manufacturing yield of Solinex rhu-pGSN

New data on Cimzia for Crohn’s Disease treatment to be demonstrated at DDW 2010

Artisan Pharma enrolls 750 patients in Phase 2b study of ART-123 in sepsis patients with DIC

miacom diagnostics announces new tests for faster diagnosis of sepsis

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Sepsis News and Research

Latest Sepsis News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in